US FDA grants Sativex fast track status for cancer pain
Nabiximols - Wikipedia
Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial | PLOS ONE
Nabiximols in MS | Experimental MS Treatments | Multiple Sclerosis News Today
Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial | PLOS ONE
Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial - The Lancet Neurology
Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity | Semantic Scholar
Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain - Journal of Pain and Symptom Management
Nabiximols - Wikipedia
Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial | PLOS ONE
Trial to test if cannabis-based mouth spray can treat brain tumours | Cancer | The Guardian
A double blind, randomised, placebo controlled trial of Sativex® for the management of cannabis withdrawal | NDARC - National Drug and Alcohol Research Centre
A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma | British Journal of Cancer
Jazz Says Cannabis-Derived Medicine Trial Missed Goals | Cannabis Equipment News
Cannabis-Derived Sativex for MS-Related Spasticity Reported to Be Effective and Safe
What's Sativex And How Does It Differ From Medical Cannabis? - RQS Blog
GW Pharma Phase 3 Trials for Sativex Miss Endpoints – New Cannabis Ventures
ALS Spasticity May Ease with Use of Sativex, Cannabis Mouth Spray, Trial Reports
Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial - The Journal of Pain
A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma | British Journal of Cancer
Life | Free Full-Text | The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms | HTML
Usability of an application device for nabiximols oromucosal spray in patients with upper limb impaired multiple sclerosis | Neurodegenerative Disease Management
![PDF] Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ff46d50dfc6424b75848bde31bd6ab11bd240824/3-Figure1-1.png "PDF] Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial. | Semantic Scholar")
PDF] Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial. | Semantic Scholar
Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial | PLOS ONE
Phase 3 Trial of Sativex, Cannabis Extract for MS Spasticity, Opens in US
Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial - The Lancet Neurology
